Issue 1/2014
Content (15 Articles)
Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)
Jair Bar, Maya Damianovich, Goni Hout Siloni, Erel Dar, Yehudit Cohen, Oranit Zadok, Yoram Cohen, Marina Perelman, Iris Barshack, Ronit I Yarden, David Simansky, Alon Ben Nun, Amir Onn
Multi-gene signatures in breast cancer: actual clinical impact
Simon P. Gampenrieder, Gabriel Rinnerthaler, Richard Greil
Breast cancer surveillance: nothing has changed in the past decades (?)
Zsuzsanna Kahán
Untreated endometrial cancer: a case report and a review of the literature
Sofie Leisby Antonsen, Jens Jørgen Kjer, Lian Ulrich
Antibody–cytotoxic drug conjugates in clinical trials and future perspectives: the development of Trojan horses
Dimitrios Tryfonopoulos
Treatment and clinical results in childhood AML in Greece
Sofia Polychronopoulou, Margarita Baka, Marina Servitzoglou, Vasilios Papadakis, Apostolos Pourtsidis, Georgia Avgerinou, Mirella Abatzidou, Helen Kosmidis
Development of treatment and clinical results in childhood acute myeloid leukemia in Slovenia in the period from 1991 to 2010
Orjana Velikonja, Milica Stefanović, Lidija Kitanovski, Helena Podgornik, Janez Jazbec
Development of treatment and clinical results in childhood AML in Austria (1993–2013)
Heidrun Boztug, Nora Mühlegger, Evgenia Glogova, Georg Mann, Christian Urban, Bernhard Meister, Klaus Schmitt, Neil Jones, Andishe Attarbaschi, Oskar Haas, Sabine Strehl, Thomas Lion, Ulrike Pötschger, Franz-Martin Fink, Helmut Gadner, Michael Dworzak